de Gomez Dumm I, de Alaniz M, Brenner R
Lipids. 2016; 13(10):649-52.
PMID: 27520107
DOI: 10.1007/BF02533740.
Habegger K, Heppner K, Geary N, Bartness T, DiMarchi R, Tschop M
Nat Rev Endocrinol. 2010; 6(12):689-97.
PMID: 20957001
PMC: 3563428.
DOI: 10.1038/nrendo.2010.187.
Wasserman D
Am J Physiol Endocrinol Metab. 2008; 296(1):E11-21.
PMID: 18840763
PMC: 2636990.
DOI: 10.1152/ajpendo.90563.2008.
Nissim I, Horyn O, Nissim I, Daikhin Y, Wehrli S, Yudkoff M
J Biol Chem. 2008; 283(22):15063-71.
PMID: 18375388
PMC: 2397462.
DOI: 10.1074/jbc.M800163200.
Barazzone P, Gorden P, Carpentier J, Orci L, Freychet P, Canivet B
J Clin Invest. 1980; 66(5):1081-93.
PMID: 7430344
PMC: 371546.
DOI: 10.1172/JCI109937.
Glucagon degradation by human mononuclear cells.
Neal G, Solomon S, Shankar T, Duckworth W
Diabetologia. 1983; 25(5):404-10.
PMID: 6317504
DOI: 10.1007/BF00282519.
Plasma adenosine 3':5'--cyclic monophosphate response to glucagon in uremia.
Vlachoyannis J, SCHOEPPE W
Klin Wochenschr. 1982; 60(13):651-7.
PMID: 6289001
DOI: 10.1007/BF01716797.
Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids.
OHNEDA A, Parada E, EISENTRAUT A, Unger R
J Clin Invest. 1968; 47(10):2305-22.
PMID: 5676526
PMC: 297395.
DOI: 10.1172/JCI105916.
Effects of glucagon on adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in human plasma and urine.
Broadus A, Kaminsky N, NORTHCUTT R, Hardman J, SUTHERLAND E, LIDDLE G
J Clin Invest. 1970; 49(12):2237-45.
PMID: 5480850
PMC: 322724.
DOI: 10.1172/JCI106442.
Liver-L-alanine-glyoxylate and L-serine-pyruvate aminotransferase activities: an apparent association with gluconeogenesis.
ROWSELL E, Snell K, CARNIE J
Biochem J. 1969; 115(5):1071-3.
PMID: 5360676
PMC: 1185249.
DOI: 10.1042/bj1151071.
[Effect of glucagon on extracellular potassium concentration measurements in aorta, hepatic vein and coronary sinus in man].
Luderitz B, AVENHAUS H, Seufert C
Klin Wochenschr. 1971; 49(24):1334-7.
PMID: 5138345
DOI: 10.1007/BF01495521.
The glycogenolytic activity of immunoreactive pancreatic glucagon in plasma.
Marco J, Faloona G, Unger R
J Clin Invest. 1971; 50(8):1650-5.
PMID: 5097572
PMC: 442065.
DOI: 10.1172/JCI106654.
The rapid changes of hepatic glycolytic enzymes and fructose-1,6-diphosphatase activities after intravenous glucagon in humans.
Greene H, TAUNTON O, Stifel F, HERMAN R
J Clin Invest. 1974; 53(1):44-51.
PMID: 4357616
PMC: 301436.
DOI: 10.1172/JCI107557.
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood.
Starzl T, Francavilla A, Halgrimson C, Francavilla F, Porter K, Brown T
Surg Gynecol Obstet. 1973; 137(2):179-99.
PMID: 4353133
PMC: 2747591.
The adaptive behaviour of isoenzyme forms of rat liver alanine aminotransferases during development.
Snell K, Walker D
Biochem J. 1972; 128(2):403-13.
PMID: 4343563
PMC: 1173776.
DOI: 10.1042/bj1280403.
Cyclic AMP and gastric secretion.
Amer M
Am J Dig Dis. 1972; 17(10):945-53.
PMID: 4342206
DOI: 10.1007/BF02239536.
[The biological role of cyclic AMP].
Rindi G
Acta Diabetol Lat. 1971; 8(5):865-98.
PMID: 4333062
DOI: 10.1007/BF01550903.
A comparison of the effects of diabetes induced with either alloxan or streptozotocin and of starvation on the activities in rat liver of the key enzymes of gluconeogenesis.
Wimhurst J, Manchester K
Biochem J. 1970; 120(1):95-103.
PMID: 4321934
PMC: 1179572.
DOI: 10.1042/bj1200095.
Some aspects of the kinetics of rat liver pyruvate carboxylase.
Wimhurst J, Manchester K
Biochem J. 1970; 120(1):79-93.
PMID: 4321933
PMC: 1179571.
DOI: 10.1042/bj1200079.
Studies on cellular autophagocytosis. Cyclic AMP- and dibutyryl cyclic AMP-stimulated autophagy in rat liver.
Shelburne J, ARSTILA A, Trump B
Am J Pathol. 1973; 72(3):521-40.
PMID: 4125701
PMC: 1904032.
